These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3050182)

  • 41. Ticarcillin/clavulanate in the treatment of pelvic infections.
    Lucas MJ; Cox SM; Roark ML; Cunningham FG
    J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
    Sparks SE; Jones RL; Kilgore WR
    Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and ticarcillin in the treatment of respiratory tract infections].
    Miki F; Ikuno Y; Inoue E; Murata A; Tanizawa S; Sakamoto K; Tahara A; Saito A; Tomizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1987 Aug; 61(8):944-79. PubMed ID: 3125285
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
    Elston RA; Swann RA; Fraise A
    J Antimicrob Chemother; 1989 Feb; 23(2):285-7. PubMed ID: 2708186
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro susceptibility of piperacillin v timentin and ticarcillin.
    Bremner DA
    N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Basic and clinical studies of ticarcillin in the pediatric field (author's transl)].
    Hori M; Kurosu Y; Toyonaga Y; Kohno S; Aoki Y; Horii J
    Jpn J Antibiot; 1978 Nov; 31(11):640-6. PubMed ID: 366198
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and piperacillin in the treatment of respiratory tract infections].
    Miki F; Ikuno Y; Inoue E; Murata A; Tanizawa S; Sakamoto K; Tahara A; Saito A; Tamizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1987 Aug; 61(8):914-43. PubMed ID: 3125284
    [No Abstract]   [Full Text] [Related]  

  • 50. Timentin resistance.
    Masterton RG; Garner PJ; Harrison NA; Rainford DJ
    Lancet; 1987 Oct; 2(8565):975-6. PubMed ID: 2889900
    [No Abstract]   [Full Text] [Related]  

  • 51. Ticarcillin-clavulanic acid zone size criteria.
    Poupard JA; Wester B
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2352. PubMed ID: 1444319
    [No Abstract]   [Full Text] [Related]  

  • 52. Timentin in the treatment of symptomatic complicated urinary tract infections in adult patients.
    Gebhart RJ; Duma RJ; Patterson PM
    Am J Med; 1985 Nov; 79(5B):101-5. PubMed ID: 3852637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative aminoglycoside inactivation by potassium clavulanate.
    Courcol RJ; Martin GR
    J Antimicrob Chemother; 1986 May; 17(5):682-4. PubMed ID: 3722038
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of ticarcillin plus clavulanic acid and piperacillin in patients with lower respiratory tract infections.
    Link AS
    Am J Med; 1985 Nov; 79(5B):86-7. PubMed ID: 4073100
    [No Abstract]   [Full Text] [Related]  

  • 55. Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid.
    Moody SB; Pawlicki KS
    Drug Intell Clin Pharm; 1987 Mar; 21(3):292-3. PubMed ID: 3569032
    [No Abstract]   [Full Text] [Related]  

  • 56. Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1980 Nov; 20(5):325-52. PubMed ID: 7002527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kluyvera cryocrescens finger infection: case report and review of eighteen Kluyvera infections in human beings.
    West BC; Vijayan H; Shekar R
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):237-41. PubMed ID: 9884842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A reassessment of ticarcillin/clavulanic acid dose recommendations for infants, children and adults.
    Reed MD
    Pediatr Infect Dis J; 1998 Dec; 17(12):1195-9. PubMed ID: 9877382
    [No Abstract]   [Full Text] [Related]  

  • 59. Adjuvant antimicrobial therapy with renal calculus surgery.
    Harrison LH; Whitehurst AW; Boyce WH
    J Urol; 1977 Aug; 118(2):233-6. PubMed ID: 894798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of ticarcillin/clavulanate into cartilage.
    Meier H; Adam D; Heilmann HD
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():101-5. PubMed ID: 2606811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.